Clinical trial
Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
NCT00017082 · Prologue Research International, Industry · Completed
Key facts
| NCT number | NCT00017082 |
|---|---|
| Title | Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer |
| Official title | A Multicenter, Phase II Study Of Oxaliplatin Single Agent As Third-Line Treatment Of Metastatic Colorectal Carcinoma |
| Lead sponsor | Prologue Research International, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Start date | Apr 1, 2001 |
| Primary completion | Jun 1, 2003 |
| Completion | Dec 1, 2010 |
| First posted | Jan 7, 2004 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: